Literature DB >> 2570230

Stage and urinary catecholamine metabolite excretion in neuroblastoma. European Neuroblastoma Study Group.

J Pritchard, J Barnes, S Germond, O Hartman, J de Kraker, I Lewis, L Lockwood, K Wallendszus.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2570230     DOI： 10.1016/s0140-6736(89)92135-1

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  5 in total

1.  Comparative values of catecholamines and metabolites for the diagnosis of neuroblastoma.

Authors:  Maud Monsaingeon; Yves Perel; Guy Simonnet; Jean-Benoît Corcuff
Journal:  Eur J Pediatr       Date:  2003-03-27       Impact factor: 3.183

2.  Poor prognosis neuroblastoma: is screening the answer?

Authors:  A W Craft; L Parker
Journal:  Br J Cancer Suppl       Date:  1992-08

3.  High-throughput molecular and histopathologic profiling of tumor tissue in a novel transplantable model of murine neuroblastoma: new tools for pediatric drug discovery.

Authors:  Jimmy K Stauffer; Rimas J Orentas; Erin Lincoln; Tahira Khan; Rosalba Salcedo; Julie A Hixon; Timothy C Back; Jun S Wei; Rajesh Patidar; Young Song; Laura Hurd; Maria Tsokos; Edwin W Lai; Graeme Eisenhofer; William Weiss; Javed Khan; Jon M Wigginton
Journal:  Cancer Invest       Date:  2012-06       Impact factor: 2.176

Review 4.  Is neuroblastoma screening evaluation needed and feasible?

Authors:  J Estève; L Parker; P Roy; F Herrmann; S Duffy; D Frappaz; C Lasset; C Hill; H Sancho-Garnier; J Michaelis
Journal:  Br J Cancer       Date:  1995-06       Impact factor: 7.640

Review 5.  Beta-Blockers and Berberine: A Possible Dual Approach to Contrast Neuroblastoma Growth and Progression.

Authors:  Maura Calvani; Angela Subbiani; Gennaro Bruno; Claudio Favre
Journal:  Oxid Med Cell Longev       Date:  2020-08-12       Impact factor: 6.543
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.